258 related articles for article (PubMed ID: 16647144)
21. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
Zschüntzsch J; Zhang Y; Klinker F; Makosch G; Klinge L; Malzahn D; Brinkmeier H; Liebetanz D; Schmidt J
J Neurochem; 2016 Jan; 136(2):351-62. PubMed ID: 26230042
[TBL] [Abstract][Full Text] [Related]
22. Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse.
Boland B; Himpens B; Denef JF; Gillis JM
Muscle Nerve; 1995 Jun; 18(6):649-57. PubMed ID: 7753128
[TBL] [Abstract][Full Text] [Related]
23. Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.
Turgeman T; Hagai Y; Huebner K; Jassal DS; Anderson JE; Genin O; Nagler A; Halevy O; Pines M
Neuromuscul Disord; 2008 Nov; 18(11):857-68. PubMed ID: 18672370
[TBL] [Abstract][Full Text] [Related]
24. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis.
Vallance BA; Gunawan MI; Hewlett B; Bercik P; Van Kampen C; Galeazzi F; Sime PJ; Gauldie J; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G116-28. PubMed ID: 15778431
[TBL] [Abstract][Full Text] [Related]
25. [Effects of gene therapy with replication-defective adenovirus ericlosing Egr-1 promoter and Smad7 cDNA on irradiation-induced pulmonary fibrosis: experiment with mice].
Wang L; Feng Y; Fu XL; Cai XW
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2847-52. PubMed ID: 17200022
[TBL] [Abstract][Full Text] [Related]
26. Characterization of thyroid fibrosis in a murine model of granulomatous experimental autoimmune thyroiditis.
Chen K; Wei Y; Sharp GC; Braley-Mullen H
J Leukoc Biol; 2000 Dec; 68(6):828-35. PubMed ID: 11129650
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.
Painemal P; Acuña MJ; Riquelme C; Brandan E; Cabello-Verrugio C
Biofactors; 2013; 39(4):467-75. PubMed ID: 23460581
[TBL] [Abstract][Full Text] [Related]
28. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
Wagner KR; McPherron AC; Winik N; Lee SJ
Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro.
Morin S; de la Porte S; Fiszman M; Koenig J
Differentiation; 1995 Oct; 59(3):145-54. PubMed ID: 7589898
[TBL] [Abstract][Full Text] [Related]
30. Neuronal TGF-beta1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice.
Mesplès B; Fontaine RH; Lelièvre V; Launay JM; Gressens P
Neurobiol Dis; 2005 Feb; 18(1):193-205. PubMed ID: 15649710
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of acetylcholine receptors in the diaphragm muscle of MDX mice.
Ghedini PC; Viel TA; Honda L; Avellar MC; Godinho RO; Lima-Landman MT; Lapa AJ; Souccar C
Muscle Nerve; 2008 Dec; 38(6):1585-94. PubMed ID: 19016551
[TBL] [Abstract][Full Text] [Related]
32. Inspiratory loading does not accelerate dystrophy in mdx mouse diaphragm: implications for regenerative therapy.
Krupnick AS; Zhu J; Nguyen T; Kreisel D; Balsara KR; Lankford EB; Clark CC; Levine S; Stedman HH; Shrager JB
J Appl Physiol (1985); 2003 Feb; 94(2):411-9. PubMed ID: 12531909
[TBL] [Abstract][Full Text] [Related]
33. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.
Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y
J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783
[TBL] [Abstract][Full Text] [Related]
35. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
[TBL] [Abstract][Full Text] [Related]
36. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta.
Vetrone SA; Montecino-Rodriguez E; Kudryashova E; Kramerova I; Hoffman EP; Liu SD; Miceli MC; Spencer MJ
J Clin Invest; 2009 Jun; 119(6):1583-94. PubMed ID: 19451692
[TBL] [Abstract][Full Text] [Related]
37. Targeting the immune system to improve ventilatory function in muscular dystrophy.
Gosselin LE; McCormick KM
Med Sci Sports Exerc; 2004 Jan; 36(1):44-51. PubMed ID: 14707767
[TBL] [Abstract][Full Text] [Related]
38. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.
Wehling-Henricks M; Sokolow S; Lee JJ; Myung KH; Villalta SA; Tidball JG
Hum Mol Genet; 2008 Aug; 17(15):2280-92. PubMed ID: 18430716
[TBL] [Abstract][Full Text] [Related]
39. Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.
Xu DQ; Zhao L; Li SJ; Huang XF; Li CJ; Sun LX; Li XH; Zhang LY; Jiang ZZ
Acta Pharmacol Sin; 2021 Jul; 42(7):1080-1089. PubMed ID: 32939036
[TBL] [Abstract][Full Text] [Related]
40. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
